AccurKardia

🚨 Exciting News! 🚨 Our ECG-powered aortic stenosis AI screening tool has received FDA Breakthrough Device Designation! This recognition marks a major milestone in our mission to expand the use of ECGs as a broad biomarker. By enabling earlier detection and better management of aortic stenosis, a critical heart condition often missed in routine care, we’re contributing to our goal of improving patient outcomes and saving lives globally. A huge thank you to the AccurKardia team for their hard work in making this happen. Special thanks to the The Texas Heart Institute team for their mentorship, and the Mayo Clinic Platform_Accelerate team, whose program expedited our clinical validation efforts. Also, a big thank you to Erik Swain and the team at Healio for covering this important achievement. Check out the full story here: https://lnkd.in/dYJ6w4JN. Stay tuned for more updates as we continue to advance the future of care, one ECG at a time. 💙 cc: Juan C Jimenez, Mohamed Sadeq Ali, Moin Hussaini, Nav Razvi, Tony M Kuttiachen, John Fox, Naveen Srinivas #ECG #CardiovascularHealth #AI #AorticStenosis #DigitalHealth #BetterOutcomes

On World Stroke Day, AccurKardia highlights the power of prevention through early detection and lifestyle changes. The AHA’s Life’s Essential 8 focuses on key areas—like physical activity, healthy diet, managing blood pressure, and quitting tobacco—that can dramatically reduce stroke risk. Learn more: https://lnkd.in/eT_qP6HS #WorldStrokeDay #StrokePrevention #GreaterThan #BetterOutcomes #AHA

✅ Day 2 at TCT 2024 is in the books! It’s been a fantastic experience so far with insightful meetings, valuable conversations, and great opportunities to showcase our technology. AccurKardia’s Chief Product Officer, Moin Hussaini, is available for meetings—reach out to us at info@accurkardia.com to connect. Don’t miss Moin’s presentation on Wednesday, where he’ll dive into the latest advancements in ECG-driven AI diagnostics, including our innovative AK-AVS technology for early detection of Aortic Valve Stenosis. Looking forward to more exciting conversations ahead at #TCT2024! #BetterOutcomes #Innovation #AI #TCT #DigitalHealth

Join us at #TCT2024 for an exciting session on AI-driven innovations in heart diagnostics! Our Chief Product Officer, Moin Hussaini, will present AccurKardia’s groundbreaking work: “Screening for Undiagnosed Aortic Stenosis in Health System EHRs Using an ECG-based AI Detection Model.” 🗓 When: Wednesday, October 30, 2024 ⏰ Time: 7:30 AM – 8:30 AM EDT 📍 Where: Innovation Theater, Innovation & Exhibit Hall (Halls A-C), Lower Level, Walter E. Washington Convention Center This session, part of TCT Innovation 14: AI-Driven Innovations in Heart Diagnostics and Imaging, will highlight how AI is transforming diagnostics and improving patient outcomes. Don’t miss it! Learn more about the conference: https://lnkd.in/eaxTVHp7

What an incredible time at HLTH USA 24! 🎉 We want to express our gratitude to everyone who stopped by the AccurKardia booth and made this event so special. A special thanks to healthtech luminaries like Alyssa Abo, MD, MBA, Stan Kachnowski PHD MPA, and Ken Nelson for your insights and inspiring conversations. We also extend our heartfelt appreciation to The Digital Health Hub Foundation - Digital Health Awards for providing a forum to highlight and diffuse healthcare innovation. Your support is instrumental in advancing solutions that will shape the future of care. HLTH continues to be an amazing platform for advancing the future of healthcare, and we’re already excited about what 2025 has in store! 🚀 Until next time, stay tuned and let’s continue driving innovation together.

Day 2 Highlights from HLTH 2024! 🚀 The energy and excitement continue at the AccurKardia booth! A big thank you to Paul Grand from MedTech Innovator for stopping by and supporting us on this incredible journey. We also had a fantastic time meeting the Scalpels & Spreadsheets team—thank you for the insightful interview and conversation! We’re thrilled to share our latest innovations, including AccurECG™, and connect with such inspiring minds driving the future of healthcare. If you’re at HLTH USA swing by our booth for a chat—we’d love to show you how we’re transforming ECG data into a powerful diagnostic and biomarker tool! Stay tuned for more updates from HLTH!

HLTH 2024 is officially underway! We’re thrilled to be here, connecting with innovators and healthcare leaders who are transforming the future of health. Our team is excited to showcase AccurKardia’s ECG-led diagnostic solutions that improve outcomes and bring efficiency to cardiac care. Stop by our booth for a live demo of our flagship product, AccurECG™, and see how we are leveraging AI to extend ECG utility far beyond traditional diagnostics. If you’re attending HLTH, we’d love to meet you! Swing by for a chat, explore collaboration opportunities, and discover how AccurKardia is shaping the future of cardiology and beyond. 📍 Find us at Booth 3254-3 Looking forward to seeing you there!

🚀 AccurKardia at HLTH USA 2024 – Join Us! 🚀 We’re excited to showcase our innovations at The Digital Health Hub Foundation - Digital Health Awards Pavilion during HLTH Inc. 2024 in Las Vegas, October 20-23! Come visit us at Booth #3254-3 to explore how we’re harnessing ECG data as a diagnostic tool and biomarker to revolutionize cardiac care. Let’s connect! If you’d like to schedule a meeting, email us at info@accurkardia.com or reach out through the event app. See you in Vegas! 🎉 #HLTH2024 #DigitalHealth #Cardiology #Innovation #AIinHealth #BetterOutcomes

We had a fantastic discussion at the Heart & Brain track panel during the MedTech Innovator Innovator Showcase. It has been an honor to be part of the inaugural cohort of this track, sponsored by the American Heart Association’s Center for Health Technology and Innovation, as part of MedTech Innovator. Thank you to AHA’s Center for Health Technology and Innovation for your strong support and to MedTech Innovator for curating such a valuable experience for all 2024 cohort companies. It’s always a pleasure sharing the stage with incredible innovators. We look forward to continuing these exciting conversations and advancing cardiac care! We’re also grateful for the opportunity to be part of the The MedTech Conference by AdvaMed this week and to showcase AccurKardia’s mission and work.

We’re excited to be at the The MedTech Conference by AdvaMed this week! As a MedTech Innovator Innovator Execution Awards finalist, we’re honored to present AccurKardia’s innovative solutions on stage. This marks a meaningful milestone as we conclude our journey in the inaugural MTI Heart & Brain Accelerator, sponsored by the American Heart Association Heart Association’s Center for Health Technology and Innovation. Looking forward to connecting with peers and sharing how we’re advancing care through ECG-led diagnostics. #MedTechConference #AdvaMed #MedTechInnovator #HeartandBrainAccelerator #BetterOutcomes